Apixaban Chemical Structure (Apixaban Struct)
Eliquis Tablet, Film Coated
Product Images NDC 50090-6454
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eliquis (NDC 50090-6454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aristotle Forest Plot (Eliquis Clin Forest Fig5)
Aristotle Major Bleeding Forest Plot (Eliquis Forest Fig1)
This is a table with data related to the effectiveness and safety of Apixaban and Warfarin for different subgroups of patients. The table includes the number of events and number of patients in different categories, as well as the hazard ratio (HR) for Apixaban versus Warfarin, representing the risk of an event occurring in patients treated with Apixaban compared to those treated with Warfarin. The table also includes the confidence interval (CI) for the HR. There are subgroups based on weight, age, gender, prior stroke or transient ischemic attack, diabetes mellitus, CHADS2 score, creatinine clearance, geographic region, and randomization status. The table suggests that Apixaban may be more effective and safer than Warfarin in many subgroups of patients. Further analysis may be necessary to confirm these findings.*
Aristotle Kaplan-meier Curve (Eliquis Km Fig4)
Effect Of Coadministered Drugs On Pharmacokinetics Of Apixaban (Eliquis Pkplot Drugs Fig2)
O:\e-submissions\pbo\products\eliquis 202155\08. Pas Esrd Dosing\01. Orig Submission\source\eliquis-pkplot-pop-fig3.jpg (Eliquis Pkplot Pop Fig3)
This is a population description table that includes information on end-stage renal disease and renal impairment (mild, moderate and severe) in individuals aged between 18-40 years and individuals with a body weight of 65-85 kg or less than 50 kg. The table also contains information on hepatic impairment and dose adjustment recommendations. However, it is not clear what type of medication or treatment this table is referring to.*
Label Image (Lbl500906454)
This is a product with the code number 9933-0 and the name or brand "LoF' ELTQUIS". The product has 5 mg of a substance called "APTXABAN". It comes with 60 tablets and should be stored at 6870 7 degrees Celsius.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
